EP1096927A4 - Composition pour le traitement du stress - Google Patents
Composition pour le traitement du stressInfo
- Publication number
- EP1096927A4 EP1096927A4 EP99934107A EP99934107A EP1096927A4 EP 1096927 A4 EP1096927 A4 EP 1096927A4 EP 99934107 A EP99934107 A EP 99934107A EP 99934107 A EP99934107 A EP 99934107A EP 1096927 A4 EP1096927 A4 EP 1096927A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- stress
- treatment
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9301398P | 1998-07-16 | 1998-07-16 | |
US93013P | 1998-07-16 | ||
PCT/US1999/016153 WO2000003701A1 (fr) | 1998-07-16 | 1999-07-16 | Composition pour le traitement du stress |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1096927A1 EP1096927A1 (fr) | 2001-05-09 |
EP1096927A4 true EP1096927A4 (fr) | 2002-09-04 |
Family
ID=22236330
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP99934107A Withdrawn EP1096927A4 (fr) | 1998-07-16 | 1999-07-16 | Composition pour le traitement du stress |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1096927A4 (fr) |
JP (1) | JP2002520353A (fr) |
CA (1) | CA2337507A1 (fr) |
WO (1) | WO2000003701A1 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR021155A1 (es) | 1999-07-08 | 2002-06-12 | Lundbeck & Co As H | Tratamiento de desordenes neuroticos |
US20050165006A1 (en) * | 2002-04-03 | 2005-07-28 | Dae-Yoon Chi | Quinoline derivatives, their preparation and pharmaceutical compositions comprising the same |
US20030232805A1 (en) * | 2002-04-24 | 2003-12-18 | Cypress Bioscience, Inc. | Prevention and treatment of functional somatic disorders, including stress-related disorders |
RU2617512C1 (ru) | 2015-10-23 | 2017-04-25 | Общество с ограниченной ответственностью "Нормофарм" | Средство с антистрессовой, анксиолитической и антидепрессивной активностью и композиция на его основе |
GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
WO2020212952A1 (fr) | 2019-04-17 | 2020-10-22 | Compass Pathfinder Limited | Traitement de la dépression et de divers autres troubles au moyen de psilocybine |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6147417A (ja) * | 1984-08-11 | 1986-03-07 | Kanebo Shokuhin Kk | 精神安定チユ−インガム |
SU1593659A1 (ru) * | 1983-12-29 | 1990-09-23 | Московская ветеринарная академия им.К.И.Скрябина | Способ профилактики стрессов у цыпл т |
WO1993016695A1 (fr) * | 1992-02-21 | 1993-09-02 | Ciba-Geigy Ag | Utilisation de la brofaromine comme agent de traitement du stress post-traumatique |
FR2710916A1 (fr) * | 1993-10-04 | 1995-04-14 | Pasteur Institut | Composés de nature peptidique ayant une activité modulatrice de la réponse sérotoninergique; applications diagnostiques et thérapeutiques. |
EP0654264A1 (fr) * | 1993-11-24 | 1995-05-24 | Eli Lilly And Company | Traitement de l'incontinence par la venlafaxine ou un aryloxy propanamine |
US5502080A (en) * | 1994-11-01 | 1996-03-26 | Hitzig; Pietr | Combined use of dopamine and serotonin agonists in the treatment of allergic disorders |
JPH0940648A (ja) * | 1995-08-02 | 1997-02-10 | Yamanouchi Pharmaceut Co Ltd | 新規な8−(2−アミノアルコキシ)キノリン誘導体 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU895334D0 (en) * | 1986-07-30 | 1990-01-28 | Sandoz Ag | Process for the preparation of nasal pharmaceutical compositions |
US5114976A (en) * | 1989-01-06 | 1992-05-19 | Norden Michael J | Method for treating certain psychiatric disorders and certain psychiatric symptoms |
SG47711A1 (en) * | 1993-06-28 | 1998-04-17 | American Home Prod | New treatments using phenehylamine derivatives |
US5597826A (en) * | 1994-09-14 | 1997-01-28 | Pfizer Inc. | Compositions containing sertraline and a 5-HT1D receptor agonist or antagonist |
US5852020A (en) * | 1996-11-22 | 1998-12-22 | Bristol-Myers Squibb Company | Nefazodone: use in treating post traumatic stress disorder |
-
1999
- 1999-07-16 JP JP2000559836A patent/JP2002520353A/ja active Pending
- 1999-07-16 WO PCT/US1999/016153 patent/WO2000003701A1/fr not_active Application Discontinuation
- 1999-07-16 EP EP99934107A patent/EP1096927A4/fr not_active Withdrawn
- 1999-07-16 CA CA002337507A patent/CA2337507A1/fr not_active Abandoned
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU1593659A1 (ru) * | 1983-12-29 | 1990-09-23 | Московская ветеринарная академия им.К.И.Скрябина | Способ профилактики стрессов у цыпл т |
JPS6147417A (ja) * | 1984-08-11 | 1986-03-07 | Kanebo Shokuhin Kk | 精神安定チユ−インガム |
WO1993016695A1 (fr) * | 1992-02-21 | 1993-09-02 | Ciba-Geigy Ag | Utilisation de la brofaromine comme agent de traitement du stress post-traumatique |
FR2710916A1 (fr) * | 1993-10-04 | 1995-04-14 | Pasteur Institut | Composés de nature peptidique ayant une activité modulatrice de la réponse sérotoninergique; applications diagnostiques et thérapeutiques. |
EP0654264A1 (fr) * | 1993-11-24 | 1995-05-24 | Eli Lilly And Company | Traitement de l'incontinence par la venlafaxine ou un aryloxy propanamine |
US5502080A (en) * | 1994-11-01 | 1996-03-26 | Hitzig; Pietr | Combined use of dopamine and serotonin agonists in the treatment of allergic disorders |
JPH0940648A (ja) * | 1995-08-02 | 1997-02-10 | Yamanouchi Pharmaceut Co Ltd | 新規な8−(2−アミノアルコキシ)キノリン誘導体 |
Non-Patent Citations (15)
Title |
---|
ACTA PSYCHIATRICA BELGICA., vol. 93, no. 3, 1993, pages 121 - 35 * |
CLINICAL NEUROPHARMACOLOGY., vol. 11, no. S1, 1988, pages s86 - s89 * |
DATABASE MEDLINE [online] 1988, BRINDLEY D N: "Metabolic and hormonal effects of dexfenfluramine on stress situations", XP002197785, Database accession no. NLM3180110 * |
DATABASE MEDLINE [online] 1993, LEPINE ET AL: "Treatment of post-traumatic stress syndrome", XP002197786, Database accession no. NLM8030427 * |
DATABASE WPI Section Ch Week 198616, Derwent World Patents Index; Class B02, AN 1986-103235, XP002197787 * |
DATABASE WPI Section Ch Week 199132, Derwent World Patents Index; Class B06, AN 1991-236275, XP002197788 * |
DATABASE WPI Section Ch Week 199716, Derwent World Patents Index; Class B02, AN 1997-175671, XP002197789 * |
DAVIDSON J R T: "BIOLOGICAL THERAPIES FOR POSTTRAUMATIC STRESS DISORDER: AN OVERVIEW", JOURNAL OF CLINICAL PSYCHIATRY, XX, XX, vol. 58, no. 9, 1997, pages 29 - 32, XP000914294, ISSN: 0160-6689 * |
FRIEDMAN M J: "DRUG TREATMENT FOR PTSD. ANSWERS AND QUESTIONS", ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, NEW YORK ACADEMY OF SCIENCES, NEW YORK, NY, US, June 1997 (1997-06-01), pages 359 - 371, XP000914298, ISSN: 0077-8923 * |
GRAEFF FREDERICO G ET AL: "Role of 5-HT in stress, anxiety and depression.", PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, vol. 54, no. 1, 1996, pages 129 - 141, XP002197781, ISSN: 0091-3057 * |
MCKITTRICK CHRISTINA R ET AL: "Serotonin receptor binding in a colony model of chronic social stress.", BIOLOGICAL PSYCHIATRY, vol. 37, no. 6, 1995, pages 383 - 393, XP002197782, ISSN: 0006-3223 * |
NEAL L A ET AL: "AN OPEN TRIAL OF MOCLOBEMIDE IN THE TREATMENT OF POST-TRAUMATIC STRESS DISORDER", INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, CLINICAL NEUROSCIENCE PUBLISHERS, LONDON, GB, vol. 12, no. 4, July 1997 (1997-07-01), pages 231 - 237, XP000884760, ISSN: 0268-1315 * |
PAPP MARIUSZ ET AL: "Pharmacological validation of the chronic mild stress model of depression.", EUROPEAN JOURNAL OF PHARMACOLOGY, vol. 296, no. 2, 1996, pages 129 - 136, XP002197783, ISSN: 0014-2999 * |
See also references of WO0003701A1 * |
ZETHOF THEO J J ET AL: "Stress-induced hyperthermia as a putative anxiety model.", EUROPEAN JOURNAL OF PHARMACOLOGY, vol. 294, no. 1, 1995, pages 125 - 135, XP002197784, ISSN: 0014-2999 * |
Also Published As
Publication number | Publication date |
---|---|
JP2002520353A (ja) | 2002-07-09 |
EP1096927A1 (fr) | 2001-05-09 |
WO2000003701A1 (fr) | 2000-01-27 |
CA2337507A1 (fr) | 2000-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0100765A3 (en) | Composition for the treatment of halitosis | |
HUP0103621A3 (en) | Fentanyl composition for the treatment of acute pain | |
GB9824436D0 (en) | Methods of treatment | |
IL138129A (en) | Composition for therapy of estrogen-associated disorders | |
AU2001233081A1 (en) | Composition for treatment of stress | |
EP1117395A4 (fr) | Composes destines au traitement de maladies liees aux oestrogenes, procedes de production et methodes d'utilisation | |
EP1096927A4 (fr) | Composition pour le traitement du stress | |
GB9812941D0 (en) | Method of treatment | |
GB9904252D0 (en) | Composition for the treatment of pain | |
GB9824893D0 (en) | Novel method of treatment | |
GB9822681D0 (en) | Method of treatment | |
HUP0103568A3 (en) | Treatment of depression | |
EG24158A (en) | Novel method of treatment | |
IL124878A0 (en) | Composition for the treatment of seborrhea | |
GB9824791D0 (en) | Novel methods of treatment | |
GB9824871D0 (en) | Novel method of treatment | |
GB9824790D0 (en) | Novel method of treatment | |
GB9824789D0 (en) | Novel method of treatment | |
SI1135128T1 (sl) | Nov postopek zdravljenja | |
GB9824208D0 (en) | Methods of treatment | |
GB9822458D0 (en) | Methods of treatment | |
GB9800707D0 (en) | Methods of treatment | |
GB9819673D0 (en) | Composition for relieving stress | |
GB9818776D0 (en) | Method of treatment | |
GB9808479D0 (en) | Method of treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20010215 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7A 61K 45/08 A, 7A 61K 31/55 B, 7A 61P 9/12 B |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20020718 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20040202 |